Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial (Q34155167)

31 July 2017

Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial (English)

1 reference

31 July 2017

liver transplantation

1 reference

1 reference

J G O'Grady

1

1 reference

31 July 2017

A Burroughs

2

1 reference

31 July 2017

P Hardy

3

1 reference

31 July 2017

D Elbourne

4

1 reference

31 July 2017

A Truesdale

5

1 reference

31 July 2017

UK and Republic of Ireland Liver Transplant Study Group

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

31 July 2017

7

1 reference

inferred from page(s)

published in

The Lancet

1 reference

31 July 2017

360

1 reference

31 July 2017

9340

1 reference

31 July 2017

1119-1125

1 reference

Defining the outcome of immunosuppression withdrawal after liver transplantation

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911196-2

7 January 2021

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911196-2

7 January 2021

Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911196-2

7 January 2021

Randomised trialomania? The multicentre liver transplant trials of tacrolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911196-2

7 January 2021

A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911196-2

7 January 2021

Two-year data from the European multicentre tacrolimus (FK506) liver study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911196-2

7 January 2021

Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911196-2

7 January 2021

Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911196-2

7 January 2021

Mechanism of enhanced vasoconstrictor hormone action in vascular smooth muscle cells by cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911196-2

7 January 2021

Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911196-2

7 January 2021

C2 monitoring strategy for optimising cyclosporin immunosuppression from the Neoral formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911196-2

7 January 2021

10.1016/S0140-6736(02)11196-2

Identifiers

DOI

1 reference

31 July 2017

1 reference